Identity
HGNC
LOCATION
3q13.33
LOCUSID
ALIAS
BXR,ONR1,PAR,PAR1,PAR2,PARq,PRR,PXR,SAR,SXR
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 8856
MIM: 603065
HGNC: 7968
Ensembl: ENSG00000144852
Variants:
dbSNP: 8856
ClinVar: 8856
TCGA: ENSG00000144852
COSMIC: NR1I2
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000144852 | ENST00000337940 | O75469 |
| ENSG00000144852 | ENST00000337940 | F1D8P9 |
| ENSG00000144852 | ENST00000393716 | J3KPQ3 |
| ENSG00000144852 | ENST00000466380 | H0Y8E2 |
Expression (GTEx)
Pathways
| Pathway | Source | External ID |
|---|---|---|
| Gene Expression | REACTOME | R-HSA-74160 |
| Generic Transcription Pathway | REACTOME | R-HSA-212436 |
| Nuclear Receptor transcription pathway | REACTOME | R-HSA-383280 |
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA10034 | bosentan | Chemical | VipGene | associated | |||
| PA10049 | cyproterone | Chemical | VipGene | associated | |||
| PA10251 | atazanavir | Chemical | ClinicalAnnotation, DataAnnotation | associated | PK | PD | 18831695, 20921307, 26174719, 26892777 |
| PA10364 | memantine | Chemical | ClinicalAnnotation | associated | PK | 23371894 | |
| PA116 | ABCC2 | Gene | Pathway | associated | 21151855 | ||
| PA123 | CYP2B6 | Gene | Pathway | associated | 21738081 | ||
| PA125 | CYP2C8 | Gene | Pathway | associated | 21151855 | ||
| PA127840611 | troleandomycin | Chemical | VipGene | associated | |||
| PA130 | CYP3A4 | Gene | Pathway | associated | 21151855, 21738081, 22722338 | ||
| PA134865839 | SLCO1B1 | Gene | DataAnnotation | associated | |||
| PA146096022 | forskolin | Chemical | VipGene | associated | |||
| PA150481189 | taxanes | Chemical | MultilinkAnnotation | associated | 27561454 | ||
| PA162355520 | nephrolithiasis | Disease | ClinicalAnnotation | associated | PK | PD | 18831695, 20921307, 26174719, 26892777 |
| PA162372840 | sunitinib | Chemical | ClinicalAnnotation | associated | PD | 25344452 | |
| PA164743137 | permethrin | Chemical | VipGene | associated | |||
| PA164745442 | penicillin v | Chemical | VipGene | associated | |||
| PA164745513 | demeclocycline | Chemical | VipGene | associated | |||
| PA164746010 | econazole | Chemical | VipGene | associated | |||
| PA164746890 | temsirolimus | Chemical | ClinicalAnnotation | associated | PK | PD | 28676933 |
| PA164748964 | sulfisoxazole | Chemical | VipGene | associated | |||
| PA164749137 | cefaclor | Chemical | VipGene | associated | |||
| PA164749649 | dicloxacillin | Chemical | VipGene | associated | |||
| PA164752250 | bexarotene | Chemical | VipGene | associated | |||
| PA164754742 | oxiconazole | Chemical | VipGene | associated | |||
| PA164781042 | flucloxacillin | Chemical | ClinicalAnnotation | associated | PD | 20222094 | |
| PA164783809 | rifapentine | Chemical | VipGene | associated | |||
| PA164924486 | st. john's wort | Chemical | VipGene | associated | |||
| PA164925725 | Toxic liver disease | Disease | ClinicalAnnotation | associated | PD | 20222094 | |
| PA165111696 | artemisinin | Chemical | VipGene | associated | |||
| PA165817016 | Kidney Transplantation | Disease | ClinicalAnnotation | associated | PK | 25271728, 29733390 | |
| PA165817398 | Myelosuppression | Disease | ClinicalAnnotation | associated | PK | PD | 28676933 |
| PA166114961 | dolutegravir | Chemical | LabelAnnotation | associated | |||
| PA166124386 | gastrointestinal toxicity | Disease | ClinicalAnnotation | associated | PK | PD | 28676933 |
| PA166151827 | adverse events | Disease | ClinicalAnnotation | associated | PK | PD | 28676933 |
| PA166156383 | rs3814055 | Variant | VipGene | associated | 16472590, 17828778, 17925385, 18381611, 20107201, 11668216 | ||
| PA166156451 | rs12721608 | Variant | VipGene | associated | 11668216 | ||
| PA244 | ABCC1 | Gene | Pathway | associated | 21151855 | ||
| PA267 | ABCB1 | Gene | DataAnnotation, Pathway | associated | 21151855 | ||
| PA390 | ABCG2 | Gene | Pathway | associated | 21151855 | ||
| PA443250 | Acquired Immunodeficiency Syndrome | Disease | ClinicalAnnotation | associated | PK | PD | 18831695, 20921307, 26174719, 26892777 |
| PA443340 | Anemia | Disease | ClinicalAnnotation | associated | PD | 24193570 | |
| PA443512 | Urinary Bladder Neoplasms | Disease | ClinicalAnnotation | associated | PK | PD | 28676933 |
| PA443750 | Colitis, Ulcerative | Disease | VipGene | associated | |||
| PA443756 | Colonic Neoplasms | Disease | ClinicalAnnotation | associated | PK | PD | 27116457 |
| PA443815 | Crohn Disease | Disease | VipGene | associated | |||
| PA443853 | Dementia | Disease | ClinicalAnnotation | associated | PK | 23371894 | |
| PA444065 | Epilepsy | Disease | ClinicalAnnotation | associated | PK | 23252947 | |
| PA445046 | Nasopharyngeal Neoplasms | Disease | ClinicalAnnotation | associated | PD | 24193570 | |
| PA445062 | Neoplasms | Disease | ClinicalAnnotation | associated | PD | 25344452 | |
| PA445204 | Ovarian Neoplasms | Disease | VipGene | associated | |||
| PA445425 | Prostatic Neoplasms | Disease | VipGene | associated | |||
| PA445601 | Osteosarcoma | Disease | VipGene | associated | |||
| PA446116 | Inflammatory Bowel Diseases | Disease | VipGene | associated | |||
| PA446411 | Endometrial Neoplasms | Disease | VipGene | associated | |||
| PA446876 | Substance-Related Disorders | Disease | ClinicalAnnotation | associated | PK | 26129906 | |
| PA447199 | Bipolar Disorder | Disease | ClinicalAnnotation | associated | PK | 26129906 | |
| PA447215 | Psychotic Disorders | Disease | ClinicalAnnotation | associated | PK | 23609392 | |
| PA447230 | HIV | Disease | ClinicalAnnotation | associated | PK | PD | 18831695, 20921307, 26174719, 26892777 |
| PA447278 | Depression | Disease | ClinicalAnnotation | associated | PK | 26129906 | |
| PA448406 | amoxicillin | Chemical | VipGene | associated | |||
| PA448419 | ampicillin | Chemical | VipGene | associated | |||
| PA448500 | atorvastatin | Chemical | VipGene | associated | |||
| PA448681 | budesonide | Chemical | VipGene | associated | |||
| PA448785 | carbamazepine | Chemical | ClinicalAnnotation, Pathway, VipGene | associated | PK | 21738081, 23252947 | |
| PA448835 | cefadroxil | Chemical | VipGene | associated | |||
| PA448868 | cefuroxime | Chemical | VipGene | associated | |||
| PA448883 | cephalexin | Chemical | VipGene | associated | |||
| PA448890 | cefradine | Chemical | VipGene | associated | |||
| PA448964 | chlorpromazine | Chemical | VipGene | associated | |||
| PA449014 | cisplatin | Chemical | VipGene | associated | |||
| PA449035 | clindamycin | Chemical | VipGene | associated | |||
| PA449057 | clotrimazole | Chemical | VipGene | associated | |||
| PA449165 | cyclophosphamide | Chemical | VipGene | associated | |||
| PA449167 | cyclosporine | Chemical | Literature, MultilinkAnnotation | associated | 24088131 | ||
| PA449247 | dexamethasone | Chemical | VipGene | associated | |||
| PA449307 | diethylstilbestrol | Chemical | VipGene | associated | |||
| PA449383 | docetaxel | Chemical | ClinicalAnnotation, VipGene | associated | PD | 24193570 | |
| PA449412 | doxorubicin | Chemical | MultilinkAnnotation | associated | 27561454 | ||
| PA449415 | doxycycline | Chemical | VipGene | associated | |||
| PA449441 | efavirenz | Chemical | VipGene | associated | |||
| PA449493 | erythromycin | Chemical | VipGene | associated | |||
| PA449685 | flutamide | Chemical | VipGene | associated | |||
| PA449688 | fluvastatin | Chemical | VipGene | associated | |||
| PA449782 | glibenclamide | Chemical | VipGene | associated | |||
| PA449814 | griseofulvin | Chemical | VipGene | associated | |||
| PA449905 | hydrocortisone | Chemical | VipGene | associated | |||
| PA449964 | ifosfamide | Chemical | VipGene | associated | |||
| PA450085 | irinotecan | Chemical | ClinicalAnnotation, MultilinkAnnotation | associated | PK | PD | 27116457, 27561454 |
| PA450112 | isoniazid | Chemical | VipGene | associated | |||
| PA450131 | isradipine | Chemical | VipGene | associated | |||
| PA450180 | lansoprazole | Chemical | VipGene | associated | |||
| PA450272 | lovastatin | Chemical | VipGene | associated | |||
| PA450395 | metformin | Chemical | Pathway | associated | 22722338 | ||
| PA450401 | methadone | Chemical | VipGene | associated | |||
| PA450486 | metyrapone | Chemical | VipGene | associated | |||
| PA450494 | miconazole | Chemical | VipGene | associated | |||
| PA450519 | minocycline | Chemical | VipGene | associated | |||
| PA450530 | modafinil | Chemical | VipGene | associated | |||
| PA450576 | nafcillin | Chemical | VipGene | associated | |||
| PA450616 | nevirapine | Chemical | VipGene | associated | |||
| PA450620 | nicardipine | Chemical | VipGene | associated | |||
| PA450631 | nifedipine | Chemical | VipGene | associated | |||
| PA450704 | omeprazole | Chemical | VipGene | associated | |||
| PA450761 | paclitaxel | Chemical | Pathway, VipGene | associated | 21151855 | ||
| PA450911 | phenobarbital | Chemical | VipGene | associated | |||
| PA450932 | phenylbutazone | Chemical | VipGene | associated | |||
| PA450947 | phenytoin | Chemical | VipGene | associated | |||
| PA450970 | pioglitazone | Chemical | VipGene | associated | |||
| PA451123 | progesterone | Chemical | VipGene | associated | |||
| PA451234 | repaglinide | Chemical | ClinicalAnnotation | associated | PK | 23807564 | |
| PA451236 | reserpine | Chemical | VipGene | associated | |||
| PA451249 | rifabutin | Chemical | VipGene | associated | |||
| PA451250 | rifampin | Chemical | ClinicalAnnotation, VipGene | associated | PK | 17925385 | |
| PA451257 | risperidone | Chemical | ClinicalAnnotation | associated | PK | 23609392, 26129906 | |
| PA451260 | ritonavir | Chemical | VipGene | associated | |||
| PA451283 | rosiglitazone | Chemical | VipGene | associated | |||
| PA451305 | saquinavir | Chemical | VipGene | associated | |||
| PA451363 | simvastatin | Chemical | VipGene | associated | |||
| PA451365 | sirolimus | Chemical | ClinicalAnnotation | associated | PK | PD | 28676933 |
| PA451483 | spironolactone | Chemical | VipGene | associated | |||
| PA451542 | sulfamethazine | Chemical | VipGene | associated | |||
| PA451550 | sulfinpyrazone | Chemical | VipGene | associated | |||
| PA451578 | tacrolimus | Chemical | ClinicalAnnotation | associated | PK | PD | 25271728, 26882121, 28777242, 29733390 |
| PA451581 | tamoxifen | Chemical | VipGene | associated | |||
| PA451614 | terbinafine | Chemical | VipGene | associated | |||
| PA451640 | tetracycline | Chemical | VipGene | associated | |||
| PA451728 | topiramate | Chemical | VipGene | associated | |||
| PA451799 | troglitazone | Chemical | VipGene | associated | |||
| PA451846 | valproic acid | Chemical | VipGene | associated | |||
| PA451877 | vinblastine | Chemical | VipGene | associated | |||
| PA451879 | vincristine | Chemical | VipGene | associated | |||
| PA451906 | warfarin | Chemical | VariantAnnotation | not associated | PD | 29298995 | |
| PA452604 | xenobiotics | Chemical | VipGene | associated |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 36503926 | 2023 | Pregnane X receptor gene variant rs7643645 and total mortality in subjects with nonalcoholic fatty liver disease. | 1 |
| 36951964 | 2023 | Effect of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of rivaroxaban and edoxaban in patients with nonvalvular atrial fibrillation. | 0 |
| 37349114 | 2023 | NEAT1_2 and DAZAP1, Paraspeckle Components, Interact with PXR to Negatively Regulate CYP3A4 Induction. | 0 |
| 36503926 | 2023 | Pregnane X receptor gene variant rs7643645 and total mortality in subjects with nonalcoholic fatty liver disease. | 1 |
| 36951964 | 2023 | Effect of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of rivaroxaban and edoxaban in patients with nonvalvular atrial fibrillation. | 0 |
| 37349114 | 2023 | NEAT1_2 and DAZAP1, Paraspeckle Components, Interact with PXR to Negatively Regulate CYP3A4 Induction. | 0 |
| 34504302 | 2022 | Polymorphisms at CYP enzymes, NR1I2 and NR1I3 in association with virologic response to antiretroviral therapy in Brazilian HIV-positive individuals. | 2 |
| 34689256 | 2022 | Expression dynamics of pregnane X receptor-controlled genes in 3D primary human hepatocyte spheroids. | 0 |
| 34862253 | 2022 | Pregnane X Receptor and the Gut-Liver Axis: A Recent Update. | 9 |
| 35053380 | 2022 | Phosphorylation-Induced Ubiquitination and Degradation of PXR through CDK2-TRIM21 Axis. | 6 |
| 35159123 | 2022 | Nuclear Receptor PXR in Drug-Induced Hypercholesterolemia. | 10 |
| 35168517 | 2022 | No Effect of PXR (8055C>T) Polymorphism on the Pharmacokinetic Profiles of Piperaquine in Healthy Chinese Subjects. | 1 |
| 35184041 | 2022 | Distinct Roles of the Sister Nuclear Receptors PXR and CAR in Liver Cancer Development. | 3 |
| 35212371 | 2022 | Molecular basis of crosstalk in nuclear receptors: heterodimerization between PXR and CAR and the implication in gene regulation. | 12 |
| 35296084 | 2022 | The Outer Membrane Lipoprotein Tp0136 Stimulates Human Platelet Activation and Aggregation Through PAR1 to Enhance G(q)/G(i) Signaling. | 4 |
Citation
Dessen P
NR1I2 (nuclear receptor subfamily 1 group I member 2)
Atlas Genet Cytogenet Oncol Haematol. 2007-02-01
Online version: http://atlasgeneticsoncology.org/gene/45797/nr1i2-(nuclear-receptor-subfamily-1-group-i-member-2)
